Valuation: MDxHealth SA

Market Cap 52.72M 60.46M 49.78M 45.2M 84.69M 5.8B 85.04M 596M 230M 2.95B 227M 222M 9.49B P/E 2026 *
-1.23x
P/E 2027 * -2.21x
Enterprise Value 173M 199M 164M 149M 279M 19.09B 280M 1.96B 757M 9.7B 747M 731M 31.23B EV / Sales 2026 *
1.8x
EV / Sales 2027 * 1.76x
Free-Float
77.86%
Yield 2026 *
-
Yield 2027 * -
1 day-6.21%
1 week-10.59%
Current month-12.52%
1 month-16.13%
3 months+16.02%
6 months-80.73%
Current year-82.35%
1 week 0.62
Extreme 0.62
0.74
1 month 0.62
Extreme 0.62
0.8
Current year 0.4
Extreme 0.4
4.34
1 year 0.4
Extreme 0.4
5.33
3 years 0.4
Extreme 0.4
5.33
5 years 0
Extreme 1.0E-5
14.3
10 years 0
Extreme 1.0E-5
61.5
Manager TitleAgeSince
Chief Executive Officer 64 2019-02-17
Director of Finance/CFO 52 2019-07-21
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 2017-10-31
Chairman 58 2017-12-31
Director/Board Member 64 2019-02-17
Date Insider Type Main position Quantity % Market Cap. Importance
8/13/26
MVM Partners LLC
BuyCompany 2,202,643 2.3084%
6/1/26 Free

Chairman

10,000 0.0195%
6/1/26 Free

Chief Executive Officer

942,200 1.8343%
Change 5-day change 1-year change 3-year change Capi.($)
-6.21%-10.59%-83.85%-82.00% 60.46M
+0.11%+2.71%+0.33%+28.59% 46.28B
-1.12%+1.78%+40.07%+27.26% 43.85B
-3.04%-6.29%+322.27%+517.36% 40.93B
-0.74%+1.25%+2.32%+67.94% 39.9B
-0.50%+0.67%+11.79%+40.51% 29.5B
-0.46%+4.22%+21.99%+124.21% 17.09B
-0.97%-10.17% - - 15.55B
-0.57%+8.12%+22.15%+38.93% 15.22B
-3.14%+31.91%-10.60% - 14.05B
Average -1.51%+2.33%+36.28%+95.35% 26.24B
Weighted average by Cap. -1.02%+1.87%+64.65%+130.18%

Financials

2026 *2027 *
Net sales 96.12M 110M 90.76M 82.42M 154M 10.58B 155M 1.09B 420M 5.38B 414M 405M 17.3B 109M 125M 103M 93.32M 175M 11.98B 176M 1.23B 475M 6.09B 469M 458M 19.59B
Net income -29.64M -33.99M -27.99M -25.41M -47.62M -3.26B -47.81M -335M -129M -1.66B -128M -125M -5.34B -18.12M -20.78M -17.11M -15.54M -29.11M -1.99B -29.23M -205M -79.09M -1.01B -78.06M -76.32M -3.26B
Net Debt 121M 138M 114M 104M 194M 13.29B 195M 1.37B 527M 6.76B 520M 509M 21.74B 139M 159M 131M 119M 223M 15.26B 224M 1.57B 605M 7.76B 597M 584M 24.97B
Logo MDxHealth SA
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Employees
364
Date Price Change Volume
26-09-18 US$0.6300 -6.21% 276,373
26-09-17 US$0.6717 -1.32% 258,784
26-09-16 US$0.6807 +1.11% 133,958
26-09-15 US$0.6732 -4.81% 132,433
26-09-14 US$0.7072 +0.37% 85,604
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.6300USD
Average target price
1.800USD
Spread / Average Target
+185.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MDXH Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!